title: Use of medication and in vivo exposure in volunteers for panic disorder research.
abstract: A survey of 794 subjects volunteering for studies of panic disorder with or without phobic avoidance revealed that fewer than 15% had received imipramine and fewer than 15% had undergone in vivo exposure, although the majority had engaged in some form of counseling and had used benzodiazepines. Subjects with spontaneous panic attacks reported more avoidance than subjects with situational attacks. One-half of the subjects were unemployed. The authors recommend wider use of the available effective treatments for panic disorder and phobic avoidance.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305-5490.
authors.forename: C B
authors.initials: CB
authors.lastname: Taylor
authors.forename: R
authors.initials: R
authors.lastname: King
authors.forename: J
authors.initials: J
authors.lastname: Margraf
authors.forename: A
authors.initials: A
authors.lastname: Ehlers
authors.forename: M
authors.initials: M
authors.lastname: Telch
authors.forename: W T
authors.initials: WT
authors.lastname: Roth
authors.forename: W S
authors.initials: WS
authors.lastname: Agras
mesh_terms: D000328:Adult; D001008:Anxiety Disorders / Q000188:drug therapy / Q000628:therapy*; D001521:Behavior Therapy; D001569:Benzodiazepines / Q000627:therapeutic use; D005239:Fear; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010200:Panic; D010698:Phobic Disorders / Q000628:therapy
chemical_list: D001569:Benzodiazepines; D007099:Imipramine